These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29844835)

  • 21. Identification of CD4
    Wang J; Yang J
    Biomed Rep; 2016 Aug; 5(2):208-212. PubMed ID: 27446543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral HLA-DR
    Hasnis E; Dahan A; Khoury W; Duek D; Fisher Y; Beny A; Shaked Y; Chowers Y; Half EE
    Front Oncol; 2020; 10():1375. PubMed ID: 32903466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
    Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.
    Huang H; Zhang G; Li G; Ma H; Zhang X
    Tumour Biol; 2015 Sep; 36(10):7987-96. PubMed ID: 25967454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
    Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
    Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
    J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells.
    Ren W; Zhang X; Li W; Feng Q; Feng H; Tong Y; Rong H; Wang W; Zhang D; Zhang Z; Tu S
    Sci Rep; 2020 May; 10(1):8056. PubMed ID: 32415175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
    Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
    Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Identification and significance of myeloid-derived suppressor cells in peripheral blood of breast cancer patients].
    Wang CQ; Wei G; Xu GY; Wang JM; Bian J; Ma MS; Wang W; Xu D; Zhou ZJ; Zhao DD; Li H
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):118-23. PubMed ID: 26899331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
    Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
    J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
    Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
    Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connecting METTL3 and intratumoural CD33
    Ni HH; Zhang L; Huang H; Dai SQ; Li J
    J Transl Med; 2020 Oct; 18(1):393. PubMed ID: 33059689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recruitment of myeloid‑derived suppressor cells and regulatory T‑cells is associated with the occurrence of acute myocardial infarction.
    Zhang M; Shi X; Zhao J; Guo W; Zhou J
    Biomed Rep; 2023 Aug; 19(2):55. PubMed ID: 37560314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.
    Khaled YS; Ammori BJ; Elkord E
    J Immunol Res; 2014; 2014():879897. PubMed ID: 24741628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
    Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
    OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
    J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic stem cell transplantation.
    Tyrinova T; Batorov E; Aristova T; Ushakova G; Sizikova S; Denisova V; Chernykh E
    Heliyon; 2024 Mar; 10(5):e26362. PubMed ID: 38434301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.